Brief: ASIT Biotech Announces Achievement Of New Clinical And Corporate Development Milestones

European Medical Solutions SA

02/05/2019 06:26

May 2 (Reuters) - ASIT BIOTECH SA  ASIT.BR :
    * ASIT BIOTECH ANNOUNCES THE ACHIEVEMENT OF NEW CLINICAL AND
CORPORATE DEVELOPMENT MILESTONES
    * TREATMENT PHASE OF CONFIRMATORY PHASE III CLINICAL STUDY
WITH
GP-ASIT+™ IN GRASS POLLEN RHINITIS IS NOW COMPLETED FOR ALL
PATIENTS
    * DSMB RECOMMENDS CONTINUING STUDY WITHOUT MODIFICATION
    * WE ALSO EXPECT TO SUCCESSFULLY COMPLETE, BY END OF Q2 OF
2019,
PRIVATE PLACEMENT OF CONVERTIBLE NOTES ANNOUNCED PREVIOUSLY -
CEO

Source text for Eikon:  ID:nBw2YD4TPa 
Further company coverage:  ASIT.BR 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))